Buy Aurobindo Pharma, Voltas; JSPL may test Rs 240-250: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Aurobindo Pharma is a buy with a stoploss of Rs 687 and target of Rs 710. Sun Pharmaceutical Advanced Research Company (SPARC) is a buy with a stoploss of Rs 475 and target of Rs 500. Voltas is a buy with a stoploss of Rs 660 and target of Rs 685."

"Tata Steel and Vedanta have moved up, now even the dogs of the sectors are likely to move. So Jindal Steel & Power for long time did not participate in the metal rally, but now it is beginning to show more momentum than even the better quality stocks. So, Rs 240-250 is easily possible there."

"I think the one stock that I like and which so far a lot of people maybe don’t have is Hindustan Copper. Out there, Rs 125-130 seems possible. So the metal rally is not a young rally, but I think now all the smaller metal stocks are kind of catching up. I think the better rallies, the space for next year could be crude, and crude related plays because that is just getting off the blocks because above USD 65 per barrel, crude seems to be having another USD 10 of headroom. So, those are the sectors of next year; things which were totally beaten and bashed up."

"Balkrishna Industries is around Rs 1,100 thereabouts. It is not a great value, like nothing is in the market, but it is a strongly trending stock and it has come off probably four or five down sessions. So for the moment, keep your stop, buy and keep a stop of Rs 1,100 and look for targets of Rs 1,400-Rs 1,450. However, it is not really bargain basement prices where things cannot go wrong, etc. If Rs 1,100 is taken out, then you need to get out of your positions. It is more a trading stock because all of these stocks inspite of bad results, etc. have been moving higher. So you trade it because the trend is strong, not because it is a great investment value, etc."